{"AdditionalFields":[{"Key":"AACROrganSiteAll","Value":""},{"Key":"AACRTrackAll","Value":""},{"Key":"CEHoursPP8","Value":""},{"Key":"LivecastUrl","Value":""},{"Key":"RelatedArticlesProgPlan","Value":""},{"Key":"SessionCategoryBasic","Value":""},{"Key":"SessionName","Value":"Exhibitor Spotlight Presentation"},{"Key":"VideoType","Value":""},{"Key":"WebcastIPSessionLink","Value":""},{"Key":"Presentation Count","Value":"3"}],"BoothSponsorshipIdForCalendar":null,"BoothSponsorshipIdForDetail":null,"BoothSponsorshipIdForResult":null,"CSlideId":null,"Color":"","ContentCaptureVendorSpecification":null,"Created":null,"Date":"2022-04-11","Description":"<p>Adaptive Biotechnologies&rsquo; immunoSEQ&reg; Technology is an end-to-end immunosequencing solution capable of profiling millions of B- and T-cell receptors at high throughput and providing a quantitative view into the immune repertoire. &nbsp;Join us at our Exhibitor Spotlight Theater titled: Utilizing immunosequencing to study oncology targets and therapies. &nbsp;Presented by Patrick Raber, Ph.D., with guest speakers Kellie N. Smith, Ph.D. and Theodore Scott Nowicki, M.D., Ph.D. to learn about:<\/p>\u000a\u000a<p>&bull; &nbsp; &nbsp; &nbsp; The principles behind the immunoSEQ Technology (Dr. Raber)<\/p>\u000a\u000a<p>&bull; &nbsp; &nbsp; &nbsp; Immuno-oncology target identification using coupled immunogenomics (Dr. Smith)<\/p>\u000a\u000a<p>&bull; &nbsp; &nbsp; &nbsp; Transgeneic T-cell receptor adoptive cell therapies: addressing epigenetic suppression &amp; optimizing therapies with immunosequencing (Dr. Nowicki) &nbsp;<\/p>\u000a","Duration":60,"EmbargoSessionContentRule":null,"EmbargoSessionContentUntil":null,"End":"4\/11\/2022 1:30:00 PM","EndTime":"13:30","HidePresentationRating":"False","HidePresentations":"False","Id":"817","Key":"ef2b91e1-7100-4191-b3a7-9c9afb5c9f6d","LastUpdated":"2022-03-25 12:18","LimitCMEToRegistrationCodes":null,"LimitMediaToRegistrationCodes":null,"Location":"Spotlight Theater B, Halls D-H","MediaSource":"None","MediaSourceDetails":null,"MediaSourceDuration":null,"MediaSourceDurationHMS":null,"Notes":null,"Number":"ESP13","OnDemand":"False","OwnerKey":null,"PlayerUrl":null,"PlayerUrlReason":null,"PrimaryCategory":"","PrimaryCategory_keys":"","PrimaryMediaItemId":null,"PrimaryMediaItemKey":null,"RuleStatus":"Incomplete","SearchResultBody":"ESP13. Adaptive Biotechnologies: Utilizing Immunosequencing to Study Oncology Targets and Therapies","SearchResultCalendarDisplayBlock":null,"SearchResultFooter":"Spotlight Theater B, Halls D-H","SearchResultHeader":"Apr 11 2022 12:30PM","SecondaryCategory":"","SecondaryCategory_keys":"","ShowChatLink":null,"Start":"4\/11\/2022 12:30:00 PM","StartTime":"12:30","Status":"Active","StreamingConfiguration":null,"StreamingKey":null,"ThumbnailUrl":null,"Title":"Adaptive Biotechnologies: Utilizing Immunosequencing to Study Oncology Targets and Therapies","Type":null,"TypeKey":null}